X
CME icon

Xponance’s CME Group CME Stock Holding History

Xponance’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
66,320
+1,554
+2% +$430K 0.09% 176
2026
Q1 		$19.1M Buy
64,766
+8,346
+15% +$2.48M 0.14% 123
2025
Q4 		$15.4M Buy
56,420
+3,103
+6% +$843K 0.12% 136
2025
Q3 		$14.4M Sell
53,317
-3,902
-7% -$1.06M 0.11% 138
2025
Q2 		$15.8M Buy
57,219
+5,095
+10% +$1.39M 0.13% 127
2025
Q1 		$13.8M Sell
52,124
-481
-0.9% -$119K 0.13% 127
2024
Q4 		$12.2M Buy
52,605
+1,458
+3% +$335K 0.11% 143
2024
Q3 		$11.3M Buy
51,147
+1,614
+3% +$334K 0.11% 149
2024
Q2 		$9.74M Sell
49,533
-1,059
-2% -$219K 0.1% 152
2024
Q1 		$10.9M Buy
50,592
+3,908
+8% +$821K 0.11% 151
2023
Q4 		$9.83M Buy
46,684
+1,989
+4% +$424K 0.12% 147
2023
Q3 		$8.95M Buy
44,695
+1,400
+3% +$278K 0.12% 141
2023
Q2 		$8.02M Sell
43,295
-394
-0.9% -$72.8K 0.11% 166
2023
Q1 		$8.37M Buy
43,689
+1,303
+3% +$236K 0.12% 152
2022
Q4 		$7.13M Buy
42,386
+5,394
+15% +$937K 0.12% 169
2022
Q3 		$6.55M Buy
36,992
+2,267
+7% +$448K 0.13% 145
2022
Q2 		$7.11M Sell
34,725
-2,826
-8% -$599K 0.14% 127
2022
Q1 		$8.93M Buy
37,551
+14,627
+64% +$3.44M 0.15% 122
2021
Q4 		$5.24M Buy
22,924
+4,669
+26% +$1.03M 0.08% 207
2021
Q3 		$3.53M Sell
18,255
-1,704
-9% -$345K 0.07% 236
2021
Q2 		$4.25M Buy
19,959
+4,589
+30% +$969K 0.08% 208
2021
Q1 		$3.14M Sell
15,370
-280
-2% -$55.1K 0.07% 234
2020
Q4 		$2.85M Buy
15,650
+1,088
+7% +$185K 0.06% 251
2020
Q3 		$2.44M Sell
14,562
-51
-0.3% -$8.59K 0.06% 246
2020
Q2 		$2.38M Buy
+14,613
New +$2.62M 0.06% 242

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Xponance's CME Position: Q2 2026 in Review

Xponance increased its CME Group (CME) stake by 2.4% in Q2 2026, buying an estimated $430K and bringing the position to 66,320 shares worth $14.6M. The position accounts for 0.09% of the portfolio, ranked #176.

Xponance first reported a position in CME in Q2 2020 and has held it in 25 quarters since. The position peaked at $19.1M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Xponance held 66,320 shares of CME Group worth $14.6M as of Q2 2026.
  • Xponance bought 1,554 CME Group shares in Q2 2026, an estimated $430K.
  • CME Group made up 0.09% of Xponance's portfolio in Q2 2026, its #176 holding.
  • Xponance first reported a position in CME Group in Q2 2020 and has held it in 25 quarters since.
  • Xponance's CME Group position peaked at $19.1M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.